In partnership with
December 1, 2025
Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.
Today we follow how new federal hemp limits, Canadian veterans’ cannabis cuts, and state-level moves in Virginia, Kentucky, and California are reshaping who gets access, who gets squeezed, and which regulators are trusted to keep fragile markets upright. Today’s edition is supported by Climatize and Superhuman AI. Their support keeps this project free for you.
🌿 Hemp cap, exports, and THC rules
🏛️ Virginia blueprint, Kentucky lobbying, California leadership
🧠 Psychedelics, “California sober,” shifting drug categories
If you want your work in front of thousands of cannabis and hemp decision-makers, reach out to talk about sponsoring an upcoming edition.
Don’t waste a crisis. Get to work.
Invest in Renewable Energy Projects Across America
Across America, communities are being powered thanks to investors on Climatize who have committed to a brighter future.
Climatize lists vetted renewable energy investment offerings in different states.
As of November 2025, over $13.2 million has been invested across 28 projects on the platform, and over $3.6 million has already been returned to our growing community of thousands of members. Returns aren’t guaranteed, and past performance does not predict future results.
On Climatize, you can explore vetted clean energy offerings, including past projects like solar farms in Tennessee, grid-scale battery storage units in New York, and EV chargers in California. Each offering is reviewed for transparency and provides a clear view of how clean energy takes shape.
Investors can access clean energy projects from $10 through Climatize. Through Climatize, you can see and hear about the end impact of your money in our POWERED by Climatize stories.
Climatize is an SEC-registered & FINRA member funding portal. Crowdfunding carries risk, including loss.
Start here — the day’s most important development, decoded for impact.
📌 What Happened: In the weeks since Congress rewrote the hemp definition, the fight has shifted from “what did they do” to “who will actually pull the trigger.” Trade groups and civil-liberties outfits are mapping litigation in three directions at once: preemption challenges on state laws that already mirrored the new cap, Commerce Clause attacks on rules that wall off in-state brands, and due-process arguments for companies that built businesses in reliance on the 2018 Farm Bill. State regulators I’ve talked with are triaging their own frameworks, deciding whether to lean into the new federal line, stall and wait for FDA or DOJ guidance, or use their marijuana programs as a pressure-release valve for products they still think serve a consumer or public health purpose. The alcohol and grocery sectors have started to run their own numbers, because every pulled hemp seltzer or gummy abandons shelf space and consumer dollars that move somewhere, even if the path is not obvious yet. Hemp advocates are building an awkward coalition with libertarian Republicans, small-government conservatives, and a slice of civil-rights lawyers who see the cap as a template for future federal crackdowns on state experiments. Inside the Beltway, the same members who pushed this language are being lobbied to support “technical fixes” that would save at least some full-spectrum and pet products, which tells you they know the blast radius reaches far beyond gas-station candy.
💡 Why It Matters: Hemp already proved that low-dose THC beverages can move through alcohol distribution to age-gated adults and that CBD products can deliver real relief to seniors, veterans, and even pets without burning down public safety. The new federal line threatens to rip that proof off shelves and leave states with a binary choice between honest cannabis frameworks or a shrinking menu of “wellness” products that no longer do much. Once Congress starts assigning acceptable THC amounts to hemp products and seltzers, it edges toward admitting that similar doses can be sold safely in medical and adult-use systems that take testing and age gates seriously. Every adjustment to this cap will surface in future debates about how far federal law should reach into state marijuana programs and what a national THC standard might look like. The outcome will decide whether those successful hemp channels become a bridge into a saner cannabis policy or a brief experiment that opponents use as an excuse to tighten the screws on both.
🧠 THC Group Take: Congress is closing out a six-year trial run that taught the country more than any white paper ever could. Hemp showed that low-dose THC drinks can move through the alcohol system to carded adults, and that CBD can live quietly, and productively, in medicine cabinets for seniors, veterans, and pets who need to take it down a notch. The whole thing may have started as an accident, a drafting gap, a so-called “loophole,” yet it turned into one of the more productive experiments federal law has stumbled into in a long time. On the right, that experience is now pulling old coalitions apart, with sheriffs and social conservatives pushing for a hard shutdown while libertarians, farm-state Republicans, and small-town business conservatives argue for rules that match how their own communities use these products. Lawmakers have clear choices in front of them: they can take “gas station weed” off the table with real standards on age checks, testing, and serving size, and they can push higher doses into medical channels where a therapeutic “dose” actually means something. If they use this moment to build a coherent THC standard instead of chasing another round of moral panic, the same fight that exposed fractures on the right can still leave the country with a straighter, more honest way of living with the plant that caused it.
Fast-moving headlines, flagged for what matters.
In 2019, cousins Jim Higdon and Eric Zipperle built Cornbread Hemp in Kentucky after Congress removed hemp from the Controlled Substances Act, betting that a stable federal definition would let them sell organic, flower-only CBD across state lines. Six years later, the same Congress has buried a new 0.4 milligram total THC per container limit in the shutdown deal, a rule that would quietly erase nearly every product in their catalog along with an estimated 95% of the hemp-derived market. Cornbread is already fighting a Tennessee law that forces out-of-state hemp brands through a three-tier alcohol-style system, a protectionist structure that makes direct-to-consumer e-commerce almost impossible for small firms. The Reason piece frames Cornbread as a test case for thousands of companies that grew under the 2018 Farm Bill and now watch Washington treat their investments and jobs as disposable collateral in a late-night compromise. The lived detail sits in a customer list full of older adults who thought they had finally found a lawful, reliable product and now have to read headlines to find out whether Congress just took it away. (Reason / Pacific Legal Foundation)
A West Virginia delegate is warning that the state’s new hemp sunset law functions more like an ax than a scalpel, threatening compliant CBD and hemp businesses alongside the “gas station chemicals” lawmakers say they want to police. The measure, passed in the wake of federal hemp turmoil, sets the state on a path to wind down broad swaths of the existing hemp economy instead of tightening definitions, serving-size limits, and age gates around intoxicating products. Small firms that built multi-state customer bases under prior rules now face a countdown clock that clouds investment, payroll, and contract decisions heading into 2026. In Charleston, it is far simpler to claim a crackdown on scary new cannabinoids than to do the slower work of drawing lines that separate bad actors from farmers and brands that followed the law. The result is a policy choice that treats rural hemp economies as expendable in service of a cleaner talking point. (WV News)
Federal refusal to permit cannabis exports keeps U.S. producers locked inside a domestic-only market even as peers build international footprints. A High Times analysis, drawing on GreenWave Advisors’ Matt Karnes, estimates that a mature $100 billion U.S. market could support roughly $10 billion a year in export value that never materializes under current rules. Countries such as Canada, Portugal, and Colombia already ship product abroad under national frameworks, and their decisions not to import U.S. cannabis function as both a lost opportunity and a quiet protective barrier for American producers. The same wall that blocks U.S. firms from global sales also keeps foreign competitors from testing how much of this market they could win on price, quality, or consistency. U.S. cannabis grows in a sealed room while the global rules and supply chains harden without much American input. (High Times)
Virginia’s Joint Commission on the Future of Cannabis Sales is set to unveil a final bill this week that would finally stand up an adult-use retail market after years of vetoes and half-finished legalization. The draft, carried by Del. Paul Krizek and Sens. Louise Lucas and Aaron Rouse, scraps the local opt-out that would have let cities and counties go “dry,” raises the local excise cap from 2.5 to 3.5%, and keeps an 8 percent state tax with some state-level deductibility to blunt 280E. The proposal leans hard into “micro-business” licensing and Virginia-based ownership, a deliberate attempt to keep big multistate operators from swallowing the market while still using the existing medical system and Metrc backbone for consumer protection. Lawmakers are targeting a November 1, 2026 retail launch under Governor-elect Abigail Spanberger, who has already said she will sign a legalization bill, which gives regulators and local governments a long but finite runway. If the General Assembly holds this line, Virginia could become the first Southern state with a retail market designed from the start to favor small in-state operators over national chains, with no dry pockets left behind for the illicit market to own. (Virginia Mercury)
Canada’s new budget leans heavily on Veterans Affairs to meet federal savings targets by trimming the cost of government-supplied cannabis for former RCMP and Armed Forces members. The department has been told to find $4.23 billion in savings over four years and says the “suite of benefits and services” will remain intact while it retools a cannabis program that now supplies tens of thousands of kilograms a year. That program started in 2008 with only a few dozen patients and just over $100,000 in annual spending, then ballooned after adult-use legalization as more veterans secured prescriptions and product volumes climbed. One tenth of the government’s broader cut package now rests on dose, pricing, and eligibility decisions inside a single drug benefit that sits at the intersection of chronic pain, PTSD, and political optics. Every future adjustment to coverage will now carry both fiscal weight in Ottawa and moral weight in veterans’ homes. (National Post via Cannabis Culture)
DEA is moving to sharply increase 2026 production quotas for multiple psychedelics, including psilocybin, psilocyn, 5-MeO-DMT, and the MDMA-analog methylone, to support research on PTSD and depression. The agency wants psilocybin output to climb from 30,000 to 40,000 grams and 5-MeO-DMT to leap from 11,000 to 30,000 grams, while methylone would jump from 5,200 to 30,000 grams in a single year. At the same time, proposed 2026 quotas for cannabis, THC, ibogaine, MDMA, LSD, and mescaline stay flat, even as DEA tells courts and Congress that science and medical need guide its scheduling and quota decisions. The notice also stresses that cannabis would fall out of this Schedule 1 quota process entirely if it moves to Schedule 3, even though DEA has already acknowledged delays in acting on that rescheduling question. The pattern points to an agency more comfortable scaling tightly controlled Schedule 1 research than resolving the basic status of the country’s most widely used illicit drug. (Marijuana Moment)
A shuttered appointment-book factory in Sidney, New York has become a Stiiizy production site, tying a flood-scarred village’s hopes to one cannabis employer. Roughly 60 workers, including former ACCO employees, are on the floor today, with plans for up to 400 jobs in a town that once had 700 calendar-plant roles and now carries empty storefronts and a shrinking tax base. That recovery arc now intersects with the state’s Omnium investigation, which alleges that major brands used a Long Island processor to manufacture products without clear sourcing and testing records, putting millions of dollars in vape inventory under a cloud. Regulators have begun proceedings to ban Omnium and have left the door open to new charges against Stiiizy, which now holds its own licenses yet could still face penalties that shut down Sidney production. Village leaders who once voted to ban retail dispensaries now study neighboring towns’ tax receipts, weighing moral discomfort against the need to refill a budget battered by floods and factory loss. For now, the town’s strategy sits with flood-height plaques in Keith Clark Park, a cavernous brick plant, and a mayor who says he is no fan of cannabis yet welcomes any legitimate company that keeps Sidney alive. (The New York Times)
New ethics filings show $9.1 million spent lobbying Kentucky’s executive branch last fiscal year, with government contractors, health interests, and medical marijuana companies all pressing for influence. Executive branch lobbying totals still lag behind the $28.1 million spent on the General Assembly in 2024, yet the new reports highlight where the real detail work happens once statutes are on the books. Medical cannabis firms now sit alongside big vendors such as Ernst & Young, AT&T, and Gainwell as they engage the same agencies that write rules, award contracts, and decide how generous or restrictive Kentucky’s new program will feel in practice. The filings also show uneven transparency, with some groups itemizing specific meetings and others offering vague descriptions that make it hard to track how cannabis rules are being shaped in real time. The margins of this new market will be set in executive-branch rooms where only the well-prepared and present have a voice. (Louisville Public Media)
Advocates are circulating an op-ed that treats Gov. Gavin Newsom’s appointment of Clint Kellum as a verdict on the “failures” of outgoing DCC Director Nicole Elliott and a chance to wipe her record clean from the narrative. The piece flags real problems, from testing controversies to burner distributors and equity money that never reached communities as promised, then pins them squarely on a department it portrays as incurious and ineffective. I have worked alongside or across the table from regulators in more jurisdictions than I can comfortably count, and none have carried a market as big, fractured, and politically loaded as California with the mix of competence, stamina, and basic human decency that Nicole brought to the job. She walked into a world of high taxes, local bans, federal illegality, an entrenched illicit market, and a three-agency merger, invited scrutiny instead of hiding from it, and still kept licenses alive, enforcement moving, and rule changes on pace with this hectic market. If California eventually steadies this system, a fair history will say the program survived long enough to improve because Nicole Elliott held it together when it easily could have broken. (Marijuana Moment)
A Brown University team built a “bar lab” and watched heavy drinkers smoke cannabis, then choose how much to drink, in conditions designed to feel like a real night out. Participants who used higher potency cannabis drank about 27% less alcohol, and those using a lower potency strain drank about 19% less, compared to a placebo session, with many delaying their first drink. A similar Colorado study found roughly a 25% drop in alcohol consumption when participants were already high, which pushes the evidence base toward a real substitution effect instead of vague anecdote. Researchers still flag serious limits, including short timeframes, controlled environments, and the fact that many subjects already met criteria for cannabis use disorder. The clinical concern is straightforward: shifting some people away from alcohol may blunt one set of harms while deepening another, in a country where “California sober” has become a self-directed experiment without clear guidance. Regulators and clinicians now face practical questions about messaging, treatment protocols, and alcohol policy in a market where cannabis is already doing quiet, unsupervised substitution work. (KQED / NPR)
Go from AI overwhelmed to AI savvy professional
AI will eliminate 300 million jobs in the next 5 years.
Yours doesn't have to be one of them.
Here's how to future-proof your career:
Join the Superhuman AI newsletter - read by 1M+ professionals
Learn AI skills in 3 mins a day
Become the AI expert on your team
From the hearing room to the comment section — we’re watching it all.
🌾 A North Carolina shop owner told reporters that Congress’s new hemp cap feels less like a rule change and more like a “terminal diagnosis” for the products that built his customer base. The state once pointed to those same gummies and tinctures as proof that it was inching toward cannabis reform, which makes the prospect of empty shelves feel like a political choice as much as an economic one. (Herald-Sun (Durham))
💼 A DFL senator and a Republican representative are making the case that Minnesota’s cannabis equity and tax problems can be tackled with the same tool: employee ownership. Their ESOP bill would turn income tax bills into retirement accounts for workers, which is a very Minnesota way to answer the question of who should actually own this new industry. (MinnPost (Community Voices: Kupec & West))
🎄 An Australian employment firm is coaching clients to treat the office Christmas party like any other worksite: documented expectations, someone sober in charge, and a plan for what happens if the night goes sideways. The advice lands in a country that still prizes pub culture, which makes the gap between “let off steam” and “legal liability” feel smaller each year. (Mondaq)